CM
SAGE

Castleark Management’s Sage Therapeutics SAGE Stock Holding History

Castleark Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,745
Closed -$1.51M – 387
2019
Q3 		$1.51M Buy
10,745
+3,355
+45% +$561K 0.06% 225
2019
Q2 		$1.35M Buy
+7,390
New +$1.26M 0.05% 234
2018
Q3 		– Sell
-22,950
Closed -$3.59M – 405
2018
Q2 		$3.59M Sell
22,950
-126
-0.5% -$19.8K 0.11% 214
2018
Q1 		$3.72M Sell
23,076
-5,419
-19% -$920K 0.12% 216
2017
Q4 		$4.69M Buy
+28,495
New +$2.76M 0.14% 197

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return